Commentary on giovanni apolone the value of a drug: From innovation to the payment via Karl Marx

Journal of Ambulatory Care Management

Volumn 31, Issue 1, 2008, Pages 61-64

  Cesario, Alfredo ^a,b  

^a CATHOLIC UNIVERSITY   (Italy)

^b IRCCS SAN RAFFAELE PISANA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

NEW DRUG;

ARTICLE; DRUG APPROVAL; DRUG SCREENING; ECONOMICS; EUROPE; LEGAL ASPECT; POLITICAL SYSTEM; STANDARD; UNITED STATES;

DRUG APPROVAL; DRUG EVALUATION; DRUGS, INVESTIGATIONAL; EUROPE; SOCIALISM; UNITED STATES;

EID: 37749007747     PISSN: 01489917     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.JAC.0000304099.43958.55     Document Type: Article

References (9)

1. Editorial. (2007). Safeguarding clinical trials. National Medicine, 13(2), 107.
2. Hearing of the Committee on Health, Education, Labor and Pension of the United States Senate. (November 16, 2006). Building a 21st century DFS: proposals to improve drug safety and innovation (pp. 76-77, 82, and 85). Retrieved October 5, 2007, from www.gpoaccess.gov/congress/senate
3. Hearn, J., & Sullivan, R. (2007). The impact of the "Clinical Trials" Directive on the cost and conduct of non-commercial cancer trials in the UK. European Journal of Cancer, 43(1), 8-13.
4. Hoey, R. (2007). The EU clinical trials directive: 3 years on. The Lancet, 365(9575), 1777-1778.
5. European Medicine for the Evaluation of Medical Products. http://www.emea.europa.eu/conference.htm#
6. European Commission, Directorate General for Research and Technology Development. (2007, October). Retrieved October 5, 2007, from http://ec.europa.eu/ research/health/imi/index_en.html
7. European Commission. The Lisbon strategy. Retrieved October 5, 2007, from http://europa.eu/ scadplus/glossary/lisbon-strategy_en.htm
8. Peto R. Trials: The next 50 years. (1998). Large scale randomised evidence of moderate benefits. BMJ. 317, 1170.
9. 72nd Workshop of the International School of Pharmacology (2007, May 24-27). Drug innovation. Erice, Italy: The Ettore Maiorana Foundation and Center for Scientific Culture.